If you have been researching ketamine for depression, you have probably come across Spravato and wondered how it compares to IV ketamine. They are related but genuinely different treatments, and understanding the difference helps you make an informed choice. Here is a clear comparison from a physician-led practice in Greenwood, Indiana that focuses on IV ketamine therapy.
What Spravato is, and how it differs from IV ketamine
Spravato is the brand name for esketamine, an FDA-approved nasal spray developed specifically for treatment-resistant depression. To understand how it differs from IV ketamine, it helps to know a bit of the chemistry. Ketamine is what is called a racemic molecule, meaning it is made of two mirror-image forms, or enantiomers: S-ketamine and R-ketamine. Spravato contains only the S form. Racemic IV ketamine, the kind we use, contains both.
This matters because research into the two enantiomers is ongoing, and there is genuine scientific interest in what the R form may contribute, something a single-enantiomer nasal spray does not include. Alongside that, IV delivery offers full bioavailability and lets a clinician adjust the dose in real time during your session, a level of precision a fixed-dose nasal spray cannot match.
Spravato does have a real advantage worth naming honestly: because it is FDA-approved for this specific use, it is covered by some insurance plans, which makes it more accessible for certain patients. IV ketamine for mood is considered off-label and is generally not covered, though HSA and FSA funds can typically be applied. The right choice depends on your clinical needs, your insurance situation, and your provider’s guidance.
What IV ketamine is
IV ketamine delivers the medication directly into your bloodstream through an infusion, administered and monitored by a clinician. Unlike a fixed-dose nasal spray, IV allows the provider to adjust the dose in real time during your session, offering a level of precision and customization that nasal delivery cannot match. As a racemic formulation, it also delivers both enantiomers of the molecule rather than a single isolated form. IV ketamine for mood is considered an off-label use, which means it is generally not covered by insurance, though HSA and FSA funds can typically be applied.
The practical differences
The main trade-offs come down to a few factors. Spravato may be more accessible if insurance coverage is essential for you. IV ketamine offers real-time dose control, full bioavailability, and the complete racemic molecule, and for many people seeking reliable relief, a delivery method with decades of clinical use behind it. Both are administered under supervision in a medical setting, which distinguishes them from unmonitored at-home ketamine. The best fit depends on your clinical needs, your insurance situation, and your provider’s guidance.
How to choose
There is no universally better option; there is a better fit for your circumstances. Someone for whom insurance coverage is the deciding factor may lean toward Spravato, while someone who values dose customization and the IV approach may prefer infusions. A good practice will help you understand your options honestly rather than steering you toward one just because it is what they offer. A free consultation is the clearest way to figure out which path makes sense for you.
Frequently Asked Questions
Is Spravato the same as ketamine?
Not exactly. Spravato is esketamine, the S-enantiomer of the ketamine molecule, delivered as an FDA-approved nasal spray for treatment-resistant depression. Racemic IV ketamine contains both the S and R enantiomers. They are related but not identical, and they differ in delivery, dose control, and insurance coverage.
What is the difference between racemic ketamine and esketamine?
Ketamine is a racemic molecule made of two mirror-image forms, S-ketamine and R-ketamine. Esketamine (Spravato) is only the S form, while racemic IV ketamine contains both. Research into what each enantiomer contributes is ongoing.
Is Spravato or IV ketamine covered by insurance?
Spravato is FDA-approved for treatment-resistant depression and is covered by some insurance plans. IV ketamine for mood is considered off-label and is generally not covered, though HSA and FSA funds can typically be applied.
What is the advantage of IV ketamine over Spravato?
IV ketamine delivers the complete racemic molecule, offers full bioavailability, and allows a clinician to adjust the dose in real time during your session, a level of precision a fixed-dose nasal spray cannot match. Both are administered under medical supervision. The best choice depends on your individual needs.
Not sure which is right for you? Call our Greenwood, Indiana office at 317-300-4091 or schedule a free consultation today.